Close Menu

NEW YORK (GenomeWeb) – A team led by researchers at the Karolinska Institute in Sweden has analyzed the proteomic landscape of breast cancer tumors, finding similar subclasses as transcriptome-based analyses but also additional ones.

Breast tumors can be divvied into five subtypes — basal-like, normal-like, HER2, luminal A, and luminal B — based on their expression of 50 transcripts, known as the PAM50, but the researchers, led by the Karolinska Institute's Janne Lehtiö, noted that many patients are still misclassified.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Jul
23

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.